Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma

NCT04926532 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Toripalimab
DRUG: Sorafenib

Sponsor

Shanghai Zhongshan Hospital